Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

Go back to Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

Tandem Diabetes (TNDM) Misses Q2 EPS by 26c

August 3, 2022 4:54 PM EDT

Tandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of ($0.24), $0.26 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $200.3 million versus the consensus estimate of $205.21 million.

GUIDANCE:

Tandem Diabetes sees FY2022 revenue of $835-845 million, versus the consensus of... More